Leucettines, a Class of Potent Inhibitors of cdc2-Like Kinases and Dual Specificity, Tyrosine Phosphorylation Regulated Kinases Derived from the Marine Sponge Leucettamine B: Modulation of Alternative

详细信息    查看全文

• 作者：Mansour Debdab ; Franc抬ois Carreaux ; Steven Renault ; Meera Soundararajan ; Oleg Fedorov ; Panagis Filippakopoulos ; Olivier Lozach ; Lucie Babault ; Tania Tahtouh ; Blandine Baratte ; Yasushi Ogawa ; Masatoshi Hagiwara ; Andreas Eisenreich ; Ursula Rauch ; Stefan Knapp ; Laurent Meijer ; Jean-Pierre Bazureau
• 刊名：Journal of Medicinal Chemistry
• 出版年：2011
• 出版时间：June 23, 2011
• 年：2011
• 卷：54
• 期：12
• 页码：4172-4186
• 全文大小：1216K
• 年卷期：v.54,no.12(June 23, 2011)
• ISSN：1520-4804

文摘

We here report on the synthesis, optimization, and biological characterization of leucettines, a family of kinase inhibitors derived from the marine sponge leucettamine B. Stepwise synthesis of analogues starting from the natural structure, guided by activity testing on eight purified kinases, led to highly potent inhibitors of CLKs and DYRKs, two families of kinases involved in alternative pre-mRNA splicing and Alzheimer鈥檚 disease/Down syndrome. Leucettine L41 was cocrystallized with CLK3. It interacts with key residues located within the ATP-binding pocket of the kinase. Leucettine L41 inhibits the phosphorylation of serine/arginine-rich proteins (SRp), a family of proteins regulating pre-RNA splicing. Indeed leucettine L41 was demonstrated to modulate alternative pre-mRNA splicing, in a cell-based reporting system. Leucettines should be further explored as pharmacological tools to study and modulate pre-RNA splicing. Leucettines may also be investigated as potential therapeutic drugs in Alzheimer鈥檚 disease (AD) and in diseases involving abnormal pre-mRNA splicing.